Camlin Fine Sciences share news, announcements and annual reports
NSE: CAMLINFINEBSE: 532834Chemicals & PetrochemicalsSmall Cap
Camlin Fine Sciences Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Mar 2007 on BSE, Jan 2015 on NSE
Last close ₹84.10up ₹1.78 (2.16%)BSE ₹84.05
Share price at the NSE close on 30 Oct 2026. Previous close ₹82.32.
30 Oct: open ₹82.32, high ₹86.09, low ₹81.00
52-week range of traded prices to 30 Oct 2026
₹78.80Low, 23 Oct 2026₹202.45High, 30 Oct 2025
- Next results date: the board meets on 3 Nov 2026 to consider: financial results and fund raising. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,616 Cr1,056th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 274.66
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹29 crore of one-off items, the largest of them in the quarter to Mar 2026.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.55
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 0.6%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹29 crore of one-off items, the largest of them in the quarter to Mar 2026.
- −2.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 0.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.67
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 6,54,30540.5% delivered
Camlin Fine Sciences share news and announcements
646 announcements, routine notices left out, newest first. Page 7 of 13.
Aug 2021
13 Aug · Results
11 Aug · Analysts
5 Aug · Board meeting
Jul 2021
23 Jul · Updates
7 Jul · Rating
Jun 2021
22 Jun · Rating
18 Jun · Disclosure
17 Jun
3 Jun · Analysts
2 Jun · Analysts
1 Jun · Legal
Exchange has sought clarification from Camlin Fine Sciences Limited with respect to announcement dated 28-May-2021, regarding Board meeting held on May 28, 2021. On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment)2. Brief details of options granted3. Whether the scheme is in terms of SEBI (SBEB) Regulations, 2014 (if applicable);4. Pricing formula;The response of the Company is awaited.
May 2021
29 May · Analysts
28 May · Board meeting
28 May · Results
26 May · Analysts
16 May · Business
16 May · Business
16 May · Business
5 May · Disclosure
Apr 2021
28 Apr · Legal
The exchange asked on 27 Apr 2021
8 Apr · Analysts
Mar 2021
2 Mar · Disclosure
1 Mar · Updates
Feb 2021
27 Feb · Analysts
27 Feb · Analysts
16 Feb · Legal
Exchange has sought clarification from Camlin Fine Sciences Limited with respect to announcement dated 10-Feb-2021, regarding Notice received from Maharashtra Pollution Control Board. On basis of above the Company is required to clarify following: 1. Expected financial implications, if any, due to compensation, penalty etc; 2. Quantum of claims, if any 3. Brief details of litigation viz. name(s) of the opposing party, court/ tribunal/agency where litigation is filed, brief details of dispute/litigation; The response of the Company is awaited.8 Feb · Board meeting
8 Feb · Results
3 Feb · Analysts
Jan 2021
27 Jan · Disclosure
Dec 2020
Nov 2020
12 Nov · Results
12 Nov · Board meeting
9 Nov · Analysts